Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonny Peter

Showing results (31-40 of 107) with videos related to

Pageof 11
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|January 4, 2026
Blistering Drug Eruptions: Diagnostic Challenges and Management in Clinical Practice Unmasking the Cause: A Grand Rounds Review of Blistering Drug EruptionAna Maria Copaescu, Michael Ardern-Jones, Natalie K Hickerson, et al.
The Cochrane Database of Systematic Reviews|October 30, 2014
The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugsGrant Theron, Jonny Peter, Marty Richardson, et al.
The Journal of Investigative Dermatology|June 6, 2022
IFN-γ ELISpot in Severe Cutaneous Adverse Reactions to First-Line Antituberculosis Drugs in an HIV Endemic SettingMireille Porter, Phuti Choshi, Sarah Pedretti, et al.
Brain, Behavior, & Immunity - Health|May 19, 2025
Acute serum protein biomarker profile and prevalence of persistent (>6 months) neuropsychiatric symptoms in a cohort of SARS-CoV-2 PCR positive patients in Cape Town, South AfricaInette van Niekerk, Monica Panieri, Talitha Müller, et al.
Frontiers in Allergy|November 5, 2025
Risk factors for angiotensin converting enzyme inhibitor angioedema in a South African populationCascia Day, Lovemore Mapahla, Melissa Ribeiro, et al.
JAAD International|May 7, 2026
Cutaneous and histopathological features of drug reaction with eosinophila and systemic symptoms differ by HIV status in an HIV-endemic settingTafadzwa Chimbetete, Bukiwe Thwala, Phuti Choshi, et al.
Immunology and Allergy Clinics of North America|November 24, 2020
Global Climate Change and Pollen Aeroallergens: A Southern Hemisphere PerspectiveJanet M Davies, Dilys Berman, Paul J Beggs, et al.
Journal of Thoracic Disease|September 28, 2019
Urine lipoarabinomannan (LAM) and antimicrobial usage in seriously-ill HIV-infected patients with sputum smear-negative pulmonary tuberculosisThuli Mthiyane, Jonny Peter, Jenny Allen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 5, 2024
Disparities in geography and race in hereditary angioedema: Analysis of 64 trials and 4354 patientsHugo W F Mak, Sophia W M So, Hilary J Longhurst, et al.
The Journal of Investigative Dermatology|December 22, 2022
HIV-Associated Immune Dysregulation in the Skin: A Crucible for Exaggerated Inflammation and HypersensitivityTafadzwa Chimbetete, Chloe Buck, Phuti Choshi, et al.
Pageof 11

Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
The Journal of Allergy and Clinical Immunology. in Practice|January 4, 2026
Blistering Drug Eruptions: Diagnostic Challenges and Management in Clinical Practice Unmasking the Cause: A Grand Rounds Review of Blistering Drug EruptionAna Maria Copaescu, Michael Ardern-Jones, Natalie K Hickerson, et al.
The Cochrane Database of Systematic Reviews|October 30, 2014
The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugsGrant Theron, Jonny Peter, Marty Richardson, et al.
The Journal of Investigative Dermatology|June 6, 2022
IFN-γ ELISpot in Severe Cutaneous Adverse Reactions to First-Line Antituberculosis Drugs in an HIV Endemic SettingMireille Porter, Phuti Choshi, Sarah Pedretti, et al.
Brain, Behavior, & Immunity - Health|May 19, 2025
Acute serum protein biomarker profile and prevalence of persistent (>6 months) neuropsychiatric symptoms in a cohort of SARS-CoV-2 PCR positive patients in Cape Town, South AfricaInette van Niekerk, Monica Panieri, Talitha Müller, et al.
Frontiers in Allergy|November 5, 2025
Risk factors for angiotensin converting enzyme inhibitor angioedema in a South African populationCascia Day, Lovemore Mapahla, Melissa Ribeiro, et al.
JAAD International|May 7, 2026
Cutaneous and histopathological features of drug reaction with eosinophila and systemic symptoms differ by HIV status in an HIV-endemic settingTafadzwa Chimbetete, Bukiwe Thwala, Phuti Choshi, et al.
Immunology and Allergy Clinics of North America|November 24, 2020
Global Climate Change and Pollen Aeroallergens: A Southern Hemisphere PerspectiveJanet M Davies, Dilys Berman, Paul J Beggs, et al.
Journal of Thoracic Disease|September 28, 2019
Urine lipoarabinomannan (LAM) and antimicrobial usage in seriously-ill HIV-infected patients with sputum smear-negative pulmonary tuberculosisThuli Mthiyane, Jonny Peter, Jenny Allen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 5, 2024
Disparities in geography and race in hereditary angioedema: Analysis of 64 trials and 4354 patientsHugo W F Mak, Sophia W M So, Hilary J Longhurst, et al.
The Journal of Investigative Dermatology|December 22, 2022
HIV-Associated Immune Dysregulation in the Skin: A Crucible for Exaggerated Inflammation and HypersensitivityTafadzwa Chimbetete, Chloe Buck, Phuti Choshi, et al.
Pageof 11